Global Primidone Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Primidone Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Primidone, sold under various brand names, is a medication used to treat seizures including partial and generalized seizures. It may also be used for essential tremors
Primidone report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Primidone market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Epilepsy and Essential Tremor are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Primidone industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Primidone key manufacturers include Valeant, Amneal Pharm, Anda Repository, Lannett, Oxford Pharms, Hikma Intl Pharms, Watson Labs, Xcel Pharmaceuticals and Valeant Pharmaceuticals International, etc. Valeant, Amneal Pharm, Anda Repository are top 3 players and held % sales share in total in 2022.
Primidone can be divided into 50mg and 250mg, etc. 50mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Primidone is widely used in various fields, such as Epilepsy, Essential Tremor and Psychiatric Disorders,, etc. Epilepsy provides greatest supports to the Primidone industry development. In 2022, global % sales of Primidone went into Epilepsy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Primidone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Valeant
Amneal Pharm
Anda Repository
Lannett
Oxford Pharms
Hikma Intl Pharms
Watson Labs
Xcel Pharmaceuticals
Valeant Pharmaceuticals International
Dr Reddys Laboratories
Impax Laboratories
Mutual Pharmaceutical
Vintage Pharmaceuticals
West Ward Pharmaceutical
Segment by Type
50mg
250mg
Epilepsy
Essential Tremor
Psychiatric Disorders
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Primidone market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Primidone, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Primidone industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Primidone in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Primidone introduction, etc. Primidone Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Primidone market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Primidone report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Primidone market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Epilepsy and Essential Tremor are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Primidone industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Primidone key manufacturers include Valeant, Amneal Pharm, Anda Repository, Lannett, Oxford Pharms, Hikma Intl Pharms, Watson Labs, Xcel Pharmaceuticals and Valeant Pharmaceuticals International, etc. Valeant, Amneal Pharm, Anda Repository are top 3 players and held % sales share in total in 2022.
Primidone can be divided into 50mg and 250mg, etc. 50mg is the mainstream product in the market, accounting for % sales share globally in 2022.
Primidone is widely used in various fields, such as Epilepsy, Essential Tremor and Psychiatric Disorders,, etc. Epilepsy provides greatest supports to the Primidone industry development. In 2022, global % sales of Primidone went into Epilepsy filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Primidone market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Valeant
Amneal Pharm
Anda Repository
Lannett
Oxford Pharms
Hikma Intl Pharms
Watson Labs
Xcel Pharmaceuticals
Valeant Pharmaceuticals International
Dr Reddys Laboratories
Impax Laboratories
Mutual Pharmaceutical
Vintage Pharmaceuticals
West Ward Pharmaceutical
Segment by Type
50mg
250mg
Segment by Application
Epilepsy
Essential Tremor
Psychiatric Disorders
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Primidone market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Primidone, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Primidone industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Primidone in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Primidone introduction, etc. Primidone Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Primidone market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.